Clinical trial
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
NCT07447050
Study timeline
Study start (actual)2025-12-23Date precision: day
Registry last updated2026-03-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Sarcomaunresolved
Gastric (Stomach) Cancerunresolved
Lung Cancerunresolved
Head and Neck Cancerunresolved
Colorectal Cancerunresolved
Ovarian Cancerunresolved
Liver Cancerunresolved
Genitourinary Cancerunresolved
Gynecologic Cancerunresolved
Interventions
RiluzoleDRUG · verified · RxNorm: riluzole
PlaceboOTHER
Sponsors & collaborators
University of California, Irvinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07447050 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.